← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2016Last known activity
Dec 8, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (12 distinct, 2 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (10 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT06114628CollaboratorPhase 2Dec 8, 2023
- NCT02980016Lead sponsorPhase 3Nov 1, 2016
Details
- Last known activity
- Dec 8, 2023